Managing bipolar disorders with the goal of achieving remission

Mina Hah, Kiki Chang

Research output: Contribution to journalArticle

Abstract

Bipolar disorder (BD), a chronic mental illness of mood disturbances, can affect persons of any age. Because BD is a disease with frequent relapses and incomplete remissions, it is challenging to manage. Over the last several years, a number of new psychopharmacologic and therapeutic tools have been developed to help attain the goal of sustained, full remission for patients. Here we review the current data on the course of BD across the life cycle and make management recommendations for achieving and maintaining complete remission without residual symptoms of BD, when possible.

Original languageEnglish (US)
Pages (from-to)36-38+41
JournalDrug Benefit Trends
Volume16
Issue number1
StatePublished - Jan 2004
Externally publishedYes

Fingerprint

Bipolar Disorder
Life Cycle Stages
Chronic Disease
Recurrence
Therapeutics

Keywords

  • Bipolar disorder
  • Depression
  • Relapse
  • Remission

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Leadership and Management

Cite this

Managing bipolar disorders with the goal of achieving remission. / Hah, Mina; Chang, Kiki.

In: Drug Benefit Trends, Vol. 16, No. 1, 01.2004, p. 36-38+41.

Research output: Contribution to journalArticle

Hah, M & Chang, K 2004, 'Managing bipolar disorders with the goal of achieving remission', Drug Benefit Trends, vol. 16, no. 1, pp. 36-38+41.
Hah, Mina ; Chang, Kiki. / Managing bipolar disorders with the goal of achieving remission. In: Drug Benefit Trends. 2004 ; Vol. 16, No. 1. pp. 36-38+41.
@article{0ff5464f4f114c88a1d2957c5ac8e8a2,
title = "Managing bipolar disorders with the goal of achieving remission",
abstract = "Bipolar disorder (BD), a chronic mental illness of mood disturbances, can affect persons of any age. Because BD is a disease with frequent relapses and incomplete remissions, it is challenging to manage. Over the last several years, a number of new psychopharmacologic and therapeutic tools have been developed to help attain the goal of sustained, full remission for patients. Here we review the current data on the course of BD across the life cycle and make management recommendations for achieving and maintaining complete remission without residual symptoms of BD, when possible.",
keywords = "Bipolar disorder, Depression, Relapse, Remission",
author = "Mina Hah and Kiki Chang",
year = "2004",
month = "1",
language = "English (US)",
volume = "16",
pages = "36--38+41",
journal = "Drug Benefit Trends",
issn = "1080-5826",
publisher = "Cliggott Publishing Co.",
number = "1",

}

TY - JOUR

T1 - Managing bipolar disorders with the goal of achieving remission

AU - Hah, Mina

AU - Chang, Kiki

PY - 2004/1

Y1 - 2004/1

N2 - Bipolar disorder (BD), a chronic mental illness of mood disturbances, can affect persons of any age. Because BD is a disease with frequent relapses and incomplete remissions, it is challenging to manage. Over the last several years, a number of new psychopharmacologic and therapeutic tools have been developed to help attain the goal of sustained, full remission for patients. Here we review the current data on the course of BD across the life cycle and make management recommendations for achieving and maintaining complete remission without residual symptoms of BD, when possible.

AB - Bipolar disorder (BD), a chronic mental illness of mood disturbances, can affect persons of any age. Because BD is a disease with frequent relapses and incomplete remissions, it is challenging to manage. Over the last several years, a number of new psychopharmacologic and therapeutic tools have been developed to help attain the goal of sustained, full remission for patients. Here we review the current data on the course of BD across the life cycle and make management recommendations for achieving and maintaining complete remission without residual symptoms of BD, when possible.

KW - Bipolar disorder

KW - Depression

KW - Relapse

KW - Remission

UR - http://www.scopus.com/inward/record.url?scp=0442278346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0442278346&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 36-38+41

JO - Drug Benefit Trends

JF - Drug Benefit Trends

SN - 1080-5826

IS - 1

ER -